Analysts across the board pointed to several near-term challenges. Legence’s ( NASDAQ: LGN) ebitda margins trail peers, free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results